Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Chemotherapy-induced amenorrhea during adjuvant therapy studied
October 20th, 2005
The effect of chemotherapy-induced amenorrhea during adjuvant therapy was studied recently by scientists in Canada. Scientists sought "To investigate the therapeutic impact of chemotherapy-induced amenorrhea in premenopausal patients with breast cancer" by conducting "a retrospective cohort study of a National Cancer Institute of Canada Clinical Trials Group phase III trial involving premenopausal patients randomized to receive cyclophosphamide, methotrexate, and fluorouracil (CMF), versus intensive cyclophosphamide, epirubicin, and fluorouracil (CEF)." W. R. Parulekar and colleagues wrote, "The objectives of our study were to describe the incidence...
Source: Women's Health Weekly (2005-10-20)
|
